Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -170,370 | -123,132 | -74,911 | -36,638 | -56,528 |
| Depreciation Amortization | -5,291 | -4,687 | -3,570 | -2,084 | -7,825 |
| Accounts payable and accrued liabilities | -2,747 | -7,569 | -6,774 | -937 | -1,656 |
| Other Working Capital | -12,669 | -9,527 | -12,761 | -3,071 | 42,846 |
| Other Operating Activity | 19,811 | 21,963 | 11,231 | 3,006 | 19,695 |
| Operating Cash Flow | $-171,266 | $-122,952 | $-86,785 | $-39,724 | $-3,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 149,293 | 83,281 | 66,267 | 22,088 | 29,023 |
| PPE Investments | -79 | -79 | -79 | -26 | N/A |
| Sale Of Investment | 7,144 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $156,358 | $83,202 | $66,188 | $22,062 | $29,023 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | 0 | 0 | 0 | -12,581 |
| Common Stock Issued | 6,425 | 2,470 | 598 | 504 | 629 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 464 |
| Financing Cash Flow | $6,425 | $2,470 | $598 | $504 | $-11,488 |
| Exchange Rate Effect | 141 | 139 | 234 | 105 | -102 |
| Beginning Cash Position | 46,074 | 46,074 | 46,074 | 46,074 | 32,109 |
| End Cash Position | 37,732 | 8,933 | 26,309 | 29,021 | 46,074 |
| Net Cash Flow | $-8,342 | $-37,141 | $-19,765 | $-17,053 | $13,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,266 | -122,952 | -86,785 | -39,724 | -3,468 |
| Capital Expenditure | -79 | -79 | -79 | -26 | N/A |
| Free Cash Flow | -171,345 | -123,031 | -86,864 | -39,750 | -3,468 |